Stock Comparison

AXSM vs REGN

Axsome Therapeutics Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

AXSM

Axsome Therapeutics Inc

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$12.44B

$66.35B

P/E (TTM)

—

15.5

Forward P/E

333.3

14.1

Price/Sales

17.6

4.5

Price/Book

227.8

2.1

EV/EBITDA

-14.8

10.5

Dividend Yield

—

0.58%

Profitability

Net Margin

-26.60%

29.60%

Operating Margin

-32.80%

20.70%

Return on Equity

-349.40%

14.50%

Return on Assets

-16.80%

6.13%

Growth (YoY)

Revenue Growth

57.40%

19.00%

Earnings Growth

0.00%

-7.20%

Price & Risk

Beta

0.6

0.2

52-Week High

$260.19

$818.90

52-Week Low

$96.09

$516.07

Analyst Target

$276.47

$833.31

Compare AXSM and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.